Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3)

about

Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.

P2860

Q41929949-432B1035-57C4-4584-A1D1-4D9A9E64E03D

P2860

Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3)

Item

http://www.wikidata.org/entity/Q37037408

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Natural Antibodies to Human Pa ...... traepithelial Neoplasia (VIN3)

@en

Natural Antibodies to Human Pa ...... rade Intraepithelial Neoplasia

@nl

type

Item

label

Natural Antibodies to Human Pa ...... traepithelial Neoplasia (VIN3)

@en

Natural Antibodies to Human Pa ...... rade Intraepithelial Neoplasia

@nl

prefLabel

Natural Antibodies to Human Pa ...... traepithelial Neoplasia (VIN3)

@en

Natural Antibodies to Human Pa ...... rade Intraepithelial Neoplasia

@nl

P1476

Natural Antibodies to Human Pa ...... traepithelial Neoplasia (VIN3)

@en

P2093

Denise A Galloway

http://www.w3.org/2001/XMLSchema#string

Elaine R Tipton

http://www.w3.org/2001/XMLSchema#string

Joseph J Carter

http://www.w3.org/2001/XMLSchema#string

Lisa G Johnson

http://www.w3.org/2001/XMLSchema#string

Margaret M Madeleine

http://www.w3.org/2001/XMLSchema#string

P2860

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels

Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women.

Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.

Cigarette smoking and variations in systemic immune and inflammation markers

Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence

Vulval intraepithelial neoplasia: current perspectives.

Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia

Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.

Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients.

P304

257-260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/LGT.0000000000000227

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David R. Doody

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27224532

http://www.w3.org/2001/XMLSchema#string

P932

4920724

http://www.w3.org/2001/XMLSchema#string

Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3)

about

P2860

P2860

Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3)

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932